Ancora Advisors’s Ocugen OCGN Stock Holding History

Ancora Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-140	Closed	-$228	–	2489
2025 Q3	$228	Buy	+140	New	+$155	﹤0.01%	1894

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ancora Advisors's OCGN Position: Q4 2025 in Review

Ancora Advisors sold out of Ocugen (OCGN) in Q4 2025, closing a stake of 140 shares — an estimated $228 sold.

Ancora Advisors first reported a position in OCGN in Q3 2025 and held it in 1 quarter. The position peaked at $228 in Q3 2025. 109 funds tracked by Wall St. Rank hold OCGN as of Q4 2025.

Ancora Advisors reported no remaining Ocugen position as of Q4 2025 after selling out during the quarter.
Ancora Advisors sold 140 Ocugen shares in Q4 2025, an estimated $228.
Ancora Advisors first reported a position in Ocugen in Q3 2025 and held it in 1 quarter.
Ancora Advisors's Ocugen position peaked at $228 in Q3 2025.
109 funds tracked by Wall St. Rank held Ocugen as of Q4 2025.

Based on Ancora Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.